| MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis M Ahdoot, AR Wilbur, SE Reese, AH Lebastchi, S Mehralivand, ... New England Journal of Medicine 382 (10), 917-928, 2020 | 678 | 2020 |
| The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease SI Sokol, V Srinivas, JP Crandall, M Kim, G Tellides, A Lebastchi, Y Yu, ... Vascular medicine 17 (6), 394-404, 2012 | 113 | 2012 |
| Contemporary treatments in prostate cancer focal therapy M Ahdoot, AH Lebastchi, B Turkbey, B Wood, PA Pinto Current opinion in oncology 31 (3), 200-206, 2019 | 109 | 2019 |
| Immune therapy and β-cell death in type 1 diabetes J Lebastchi, S Deng, AH Lebastchi, I Beshar, S Gitelman, S Willi, ... Diabetes 62 (5), 1676-1680, 2013 | 104 | 2013 |
| Modern experience with aggressive parathyroid tumors in a high-volume New England referral center CE Quinn, J Healy, AH Lebastchi, TC Brown, JE Stein, ML Prasad, ... Journal of the American College of Surgeons 220 (6), 1054-1062, 2015 | 83 | 2015 |
| Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus AH Lebastchi, AK George, TJ Polascik, J Coleman, J de la Rosette, ... European urology 78 (3), 371-378, 2020 | 80 | 2020 |
| Thyroid cancer AH Lebastchi, GG Callender Current problems in cancer 38 (2), 48-74, 2014 | 72 | 2014 |
| Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells B Fogal, T Yi, C Wang, DA Rao, A Lebastchi, S Kulkarni, G Tellides, ... The Journal of Immunology 187 (12), 6268-6280, 2011 | 64 | 2011 |
| Adrenocortical carcinoma: current therapeutic state‐of‐the‐art AH Lebastchi, JW Kunstman, T Carling Journal of oncology 2012 (1), 234726, 2012 | 46 | 2012 |
| The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) global surgical collaboration project: development of criteria for reporting adverse … GE Cacciamani, T Sholklapper, P Dell'Oglio, B Rocco, F Annino, ... European Urology Focus 8 (6), 1847-1858, 2022 | 43 | 2022 |
| Nationwide survey of US integrated 6-year cardiothoracic surgical residents AH Lebastchi, DD Yuh The Journal of thoracic and cardiovascular surgery 148 (2), 401-407, 2014 | 43 | 2014 |
| Real-time super selective venous sampling in remedial parathyroid surgery AH Lebastchi, JE Aruny, PI Donovan, CE Quinn, GG Callender, T Carling, ... Journal of the American College of Surgeons 220 (6), 994-1000, 2015 | 42 | 2015 |
| The urology applicant: an analysis of contemporary urology residency candidates AH Lebastchi, RK Khouri Jr, ID McLaren, GJ Faerber, KH Kraft, KS Hafez, ... Urology 115, 51-58, 2018 | 41 | 2018 |
| Multi-institutional survival analysis of incidental pathologic T3a upstaging in clinical T1 renal cell carcinoma following partial nephrectomy CM Russell, AH Lebastchi, J Chipollini, A Niemann, R Mehra, TM Morgan, ... Urology 117, 95-100, 2018 | 40 | 2018 |
| IFN-γ Primes Intact Human Coronary Arteries and Cultured Coronary Smooth Muscle Cells to Double-Stranded RNA-and Self-RNA–Induced Inflammatory Responses by Upregulating TLR3 … U Ahmad, R Ali, AH Lebastchi, L Qin, SL Lo, AO Yakimov, SF Khan, ... The Journal of Immunology 185 (2), 1283-1294, 2010 | 40 | 2010 |
| Using Prostate Imaging-Reporting and Data System (PI-RADS) scores to select an optimal prostate biopsy method: a secondary analysis of the Trio study M Ahdoot, AH Lebastchi, L Long, AR Wilbur, PT Gomella, S Mehralivand, ... European urology oncology 5 (2), 176-186, 2022 | 38 | 2022 |
| The role of transurethral resection in trimodal therapy for muscle-invasive bladder cancer CM Russell, AH Lebastchi, T Borza, DE Spratt, TM Morgan Bladder Cancer 2 (4), 381-394, 2016 | 37 | 2016 |
| Role of multiparametric prostate MRI in the management of prostate cancer LP O’Connor, AH Lebastchi, R Horuz, AR Rastinehad, MM Siddiqui, ... World Journal of Urology 39, 651-659, 2021 | 36 | 2021 |
| Activation of human vascular cells decreases their expression of transforming growth factor-beta AH Lebastchi, L Qin, SF Khan, J Zhou, A Geirsson, RW Kim, W Li, ... Atherosclerosis 219 (2), 417-424, 2011 | 31 | 2011 |
| TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease RS Al-Lamki, W Lu, J Wang, J Yang, TJ Sargeant, R Wells, C Suo, ... Stem Cells 31 (9), 1881-1892, 2013 | 26 | 2013 |
Michael AhdootCedars-Sinai Medical Center在 cshs.org 的电子邮件经过验证
